RXO, Inc. (RXO) Stock Forecast
Data as of Sep 16, 2026Industrials · Current price $18.90 (-3.42%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 9, 2026 | Lucas Servera | Truist Financial | $20.00 | +5.8% |
| Jan 15, 2026 | Lucas Servera | Truist Financial | $18.00 | -4.8% |
| Nov 11, 2025 | Ravi Shanker | Morgan Stanley | $19.00 | +0.5% |
| Oct 10, 2025 | Bruce Chan | Stifel Nicolaus | $17.00 | -10.1% |
| Apr 24, 2025 | Lucas Servera | Truist Financial | $19.00 | +0.5% |
| Jan 7, 2025 | Christian Wetherbee | Wells Fargo | $28.00 | +48.1% |
| Nov 18, 2024 | Jordan Alliger | Goldman Sachs | $29.00 | +53.4% |
| Oct 8, 2024 | Ariel Rosa | Citigroup | $33.00 | +74.6% |
| Sep 26, 2024 | Bascome Majors | Susquehanna | $16.00 | -15.3% |
| Sep 17, 2024 | Scott Schneeberger | Oppenheimer | $31.00 | +64.0% |
| Sep 11, 2024 | Stephanie Moore | Jefferies | $31.00 | +64.0% |
| Jul 8, 2024 | Daniel Imbro | Stephens | $25.00 | +32.3% |
| Jun 25, 2024 | Bruce Chen | Stifel Nicolaus | $26.00 | +37.6% |
| Jun 24, 2024 | Stephanie Moore | Jefferies | $30.00 | +58.7% |
| Jun 20, 2024 | Tom Wadewitz | UBS | $22.00 | +16.4% |
| Apr 11, 2024 | Scott Group | Wolfe Research | $15.00 | -20.6% |
| Jun 9, 2023 | Bascome Majors | Susquehanna | $20.00 | +5.8% |
Top Analysts Covering RXO
RXO vs Sector & Market
| Metric | RXO | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.81 | 2.40 | 2.42 |
| Analyst Count | 21 | 8 | 18 |
| Target Upside | +34.0% | +112.1% | +19.5% |
| P/E Ratio | -32.93 | 34.76 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.49B | $5.80B | $6.09B | 15 |
| 2027-03-31 | $1.31B | $1.43B | $1.55B | 5 |
| 2027-06-30 | $1.41B | $1.54B | $1.66B | 6 |
| 2027-09-30 | $1.48B | $1.61B | $1.74B | 9 |
| 2027-12-31 | $1.55B | $1.69B | $1.83B | 5 |
| 2028-03-31 | $1.55B | $1.69B | $1.83B | 4 |
| 2028-06-30 | $1.58B | $1.72B | $1.86B | 6 |
| 2028-09-30 | $1.60B | $1.75B | $1.89B | 9 |
| 2028-12-31 | $1.63B | $1.78B | $1.92B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.13 | $-0.02 | $0.02 | 12 |
| 2027-03-31 | $-0.02 | $-0.01 | $-0.01 | 5 |
| 2027-06-30 | $0.08 | $0.09 | $0.10 | 5 |
| 2027-09-30 | $0.12 | $0.13 | $0.14 | 5 |
| 2027-12-31 | $0.16 | $0.18 | $0.20 | 5 |
| 2028-03-31 | $-0.02 | $-0.02 | $-0.02 | 7 |
| 2028-06-30 | $0.12 | $0.14 | $0.15 | 6 |
| 2028-09-30 | $0.11 | $0.12 | $0.14 | 6 |
| 2028-12-31 | $0.09 | $0.11 | $0.12 | 7 |
Frequently Asked Questions
What is the analyst consensus for RXO?
The consensus among 21 analysts covering RXO, Inc. (RXO) is Hold with an average price target of $24.00.
What is the highest price target for RXO?
The highest price target for RXO is $33.00, set by Ariel Rosa at Citigroup on 2024-10-08.
What is the lowest price target for RXO?
The lowest price target for RXO is $15.00, set by Scott Group at Wolfe Research on 2024-04-11.
How many analysts cover RXO?
21 analysts have issued ratings for RXO, Inc. in the past 12 months.
Is RXO a buy or sell right now?
Based on 21 analyst ratings, RXO has a consensus rating of Hold (2.81/5) with a +34.0% upside to the consensus target of $24.00.
What are the earnings estimates for RXO?
Analysts estimate RXO will report EPS of $-0.02 for the period ending 2026-12-31, with revenue estimated at $5.80B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.